GH exerts a wide variety of biological actions in many different tissues and cell types. The actions of GH at the cellular level can be divided into three categories: metabolic, mitogenic and differentiation. Metabolic effects of GH have been well documented and characterized in adipocytes. The major effect of GH in adipocytes from intact animals is an anti insulin-like or diabetogenic effect [1] , where GH treatment leads to decreased glucose utilization and lipogenesis and increased lipolysis [2] . In contrast, in adipocytes from hypophysectomized animals GH exhibits insulin-like effects including increased glucose uptake and stimulation of lipogenesis [3] . The metabolic effects of GH have been described in skeletal muscle, heart and kidney where both glucose and amino acid uptake are stimulated by GH [4] as well as an increase in general protein biosynthesis.
Proliferative effects of GH have been described in liver, kidney and heart after in vivo administration of GH [5] . Evidence for a direct effect on cell proliferation has been provided by in vitro experiments in which it has been described that GH can stimulate the mitotic activity of many different cell types [6] [7] [8] . In pancreatic f3-cells GH was found to increase the mitotic activity 10-fold by an insulin-like growth factor 1 (IGF-1) independent mechanism [9] . Direct effects of GH on cell proliferation have also been described in cultured chondrocytes [6] , smooth muscle cells [10] and thymocytes [11] . Differentiation of preadipocytes into mature adipocytes is known to be regulated by GH [12] . In preadipocyte cell lines GH promotes the differentiation of the fibroblastlike preadipocytes into lipid and triglyceride synthesizing adipocytes.
However, in primary preadipocytes of both rat or human origin, GH will inhibit differentiation induced by insulin [13] . In vivo GH exhibits anti-lipogenic activity and causes a marked reduction in fat cell mass in rats, pigs and man. Chondrocytes from the epiphysal growth plate differentiate in response to GH. The differentiated chondrocytes express IGF-1 which acts as an auto-or paracrine growth factor to stimulate cell proliferation resulting in bone growth [14] . GH also affects the development of thymocyte progenitor cells in bone marrow as well as cells in the haemopoietic system [15] .
Many of the effects of GH described above have been shown to be mediated by a specific GH receptor.
The gene encoding the human GH receptor was first cloned in 1987 [16] . The primary structure predicted a single chain transmembrane protein of approximately 620 amino acids. The peptide sequence of the entire receptor showed homology to the PRL receptor while the extracellular domain was also found to share homology with receptors of the cytokine receptor superfamily [17] . In the intracellular domain of the GH receptor no obvious homology to any other known receptor or signalling molecule could be identified, other than a very short proline-rich region located in the membrane proximal domain. The primary structure of the GH receptor revealed very little information concerning the signalling pathways initiated by the binding of GH to its receptor.
It was not until 1993, with the identification of the binding and activation of JAK-2 kinase to the activated GH receptor that the initial events in GH signalling could be demonstrated [18] . Subsequent to this finding it has become evident that the activation of JAK-2 kinase by the GH receptor is a prerequisite for almost all intracellular signalling by the GH receptor.
An important question in the understanding of GH action at the cellular and molecular levels is how the various signalling events initiated by the GH receptor regulate the diverse biological actions of GH. In this chapter we will try to review the important findings that has lead to the identification of specific domains in the intracellular part of the GH receptor required for the initiation of various signalling pathways and how these diverse pathways regulate cell metabolism, proliferation and differentiation.
Activation of JAK-2 by GH
Specific GH induced tyrosine phosphorylation of the GH receptor has been described in several different cell types [19] . However, since the primary structure of the GH receptor revealed that this receptor does not contain intrinsic tyrosine kinase activity, the presence of a GH receptor associated tyrosine kinase was suggested. In 1993 the cytoplasmic tyrosine kinase JAK-2 was reported to be activated by GH and to associate to the GH receptor upon GH stimulation [18] . Stimulation of cells with GH results in the rapid activation of JAK-2 kinase activity and the subsequent phosphorylation of both the GH receptor and JAK-2 itself.
Following this observation it was determined that all members of the cytokine receptor superfamily utilize one or more of the members of the JAK family of tyrosine kinases. Experiments using mutated GH receptors have shown that the conserved proline-rich domain (box-1) located near the transmembrane domain is involved in the binding of JAK-2 ( Fig. 1) . Mutation of this box-1 region either by deletion or by mutating the four prolines to alanines results in a GH receptor which is unable to bind and activate JAK-2 despite normal GH binding [20] . Similarly in the other receptors of the cytokine receptor superfamily this proline-rich domain has been reported to be required for activation of JAK family kinase. The importance of JAK-2 kinase in GH phosphorylation. The region of the GH receptor involved in IRS-1 and 2 activation is identical to that required for JAK-2 activation (Fig. 1) . The majority of the Cterminal part of the GH receptor is dispensable whereas the box-1 region is required [21] . Tyrosine phosphorylation of the GH receptor is not important for IRS-1 and 2 activation by GH, indicating that IRS-1 and 2 might interact directly with phosphotyrosines on JAK-2 and not on the GH receptor. In addition to its insulin and anti insulin-like effects, GH also stimulates general protein biosynthesis in many cell types. In CHO cells transf ected with the GH receptor, GH will stimulate protein biosynthesis and lipogenesis [23] . The signalling pathway leading to these effects are not known, but studies using mutated GH receptors have shown that in addition to the box-1 region, specific tyrosines in the GH receptor are important. If tyrosines 333 and 338 are mutated to phenylalanines this receptor can no longer mediate GH effects on protein biosynthesis and lipogenesis [24] . Since it has been shown that GH induces the phosphorylation of one or both of these tyrosines [25] , it might be speculated that signalling molecules involved in mediating these pathways bind directly to the phosphorylated tyrosines 333 and/or 338. However the nature and signalling ability of such factors remain unknown.
Nuclear
Effects of GH As most of the effects of GH on cell proliferation and differentiation are believed to result from changes in gene expression this area has received great attention. The expression level of a large number of genes has been shown to be regulated by GH, including IGF-1, IGF-1 binding protein 3, insulin, somatostatin, c-fos, c jun and the serine protease inhibitor Spi 2.1 [26] . Regulation of gene transcription by GH has in many cases been shown to be the major site at which GH regulates gene expression. Furthermore, GH responsive promoter elements have been identified in several genes. In insulin producing cells it was observed that GH can stimulate the steady state level of insulin mRNA, resulting in increased insulin biosynthesis [27] . Using the insulin promoter directing the expression of the reporter gene, CAT, it was observed that GH directly stimulates transcription of the insulin gene. Similar results were obtained using nuclear run off assays. Mutational analysis of the GH receptor revealed that the box 1 region was required and that in addition to this, elements in the C-terminal part of the GH receptor were also required for transcriptional signalling [28] (Fig.  1) . This is in contrast to regions required for metabolic signalling where most of the C-terminal part of the GH receptor is dispensable. Tyrosine phosphorylation was found to be required for GH stimulated insulin and Spi 2.1 gene transcription since a GH receptor in which all intracellular tyrosines were mutated to phenylalanines failed to stimulate transcription despite normal MAP kinase activation. Three tyrosines: 534,566 and 627 were found to be involved in transcriptional signalling [28] . Their role in this response was analyzed by testing their ability to bind Stat factors, a class of transcription factors known to be activated by cytokine receptors. Stat 5 was found to interact directly with the phosphorylated GH receptor and phosphorylated tyrosines 534, 566 and 627 were specifically involved in this binding. The fact that the same three tyrosines are required for transcriptional signalling strongly suggests that GH induced Stat 5 receptor binding and activation is directly mediating GH regulated gene transcription [29] (Fig. 2) . In support of this hypothesis specific promoter elements from both the insulin and Spi 2.1 genes were found to be able to bind Stat 5. Furthermore when GH receptors containing only one of the three tyrosines 534, 566 or 627 these receptors are able to mediate GH stimulated transcription as well as to activate the DNA binding activity of Stat 5. The presence of Stat 5 binding sites in several GH regulated genes indicates the importance of this transcription factor in GH regulated transcription.
In contrast to the transcriptional effects of GH described above, GH can regulate the expression of immediate early genes such as c f os and c-jun by a mechanism that is independent of GH receptor tyrosine phosphorylation [30] . In the case of GH stimulated c-fos expression it was observed that the C-terminal region of the GH receptor was not required. GH stimulates c f os transcription via the serum response element present in the c-fos promoter. This element has been reported to be regulated by many growth factors which stimulate the MAP kinase pathway. GH also induces the binding of nuclear factors to the serum response element of c-fos. Since GH is known to stimulate the MAP kinase pathway [31] it seems likely that this pathway is also involved in GH regulation of c fos expression. However, GH also induces the binding of homo-and heterodimers of Stats 1 and 3 to the sis inducible element in the c-fos promoter. As in the MAP kinase pathway the activation of Stats 1 and 3 by GH does not require GH receptor tyrosine phosphorylation [32] . The precise role of each of these pathways in the regulation of the cf os gene is not known. Irrespective of which pathways are utilized for the induction of c-fos, it seems likely that these pathways are involved directly in the stimulation of cell proliferation by GH.
Conclusions
Significant progress in the understanding of the molecular mechanism of GH action has been achieved since the cloning of the GH receptor cDNA in 1987. The initial event in GH signalling following GH induced dimerization of the receptor is the binding and activation of the cytoplasmic tyrosine kinase JAK-2. The importance of this molecule in GH signalling is evident from the studies of mutated GH receptors which are unable to bind and activate JAK-2. In cells expressing such receptors GH is not able to activate any known signalling pathways nor does it exert any biological function except for Ca-uptake [33] . In addition, JAK-2 kinase inhibitors are able to inhibit many biological actions of GH in different cell types.
Following the activation of JAK-2, several distinct signalling pathways are initiated. Phosphorylation of IRS-1 and 2 presumably results in the activation of metabolic pathways including the activation of p85 subunit of PI-3 kinase leading to increased glucose uptake. Activation of the SHC, Grb-2, ras, MAP kinase pathway seems to be initiated by the activation of JAK-2 and phosphotyrosines on JAK-2 itself seem to be involved in the initial activation of SHC. The MAP kinase pathway is believed to be mediating the mitogenic signalling by GH. Binding sites for Stats 1 and 3 might also be present in the phosphorylated JAK-2 itself since no GH receptor tyrosines are required for Stats 1 and 3 activation and since a chimeric GH receptor in which the entire intracellular domain has been replaced by the kinase domain of JAK-2 is able to activate Stats 1 and 3 as well as proliferation [34] . The down stream signalling targets for Stats 1 and 3 are not known although the c-fos promoter contains binding sites for Stats 1 and 3. GH activation of genes characterized by differentiated cell function such as the insulin and Spi 2.1 genes requires, in addition to JAK-2 activation also an element in the C-terminal part of the GH receptor. In particular three tyrosines have been identified which are involved in GH stimulated insulin and Spi 2.1 transcription. The function of these tyrosines when phosphorylated is to act as binding sites for Stat 5. Upon binding of Stat 5 to the activated GH receptor, Stat 5 become phosphorylated on a specific typrosine residue, dimerizes and translocates to the Hypothetical model for GH receptor induced activation of Stat 5 transcriptional activity. Following GH induced dimerization of the GH receptor the cytoplasmic tyrosine kinase JAK-2 binds to the GH receptor and phosphorylates specific tyrosine residues in the intracellular domain.
These phosphotyrosines serve as binding sites for Stat 5, which upon binding to the GH receptor serve as substrates for JAK-2. Phosphorylation of a specific tyrosine residue in the C-terminal part of Stat 5 allows for Stat 5 dimerization, followed by nuclear translocation, DNA binding and transcriptional activation. 
